Myeloma aetiology and epidemiology

Biomedicine and Pharmacotherapy

Volumn 56, Issue 5, 2002, Pages 223-234

  Morgan, G J ^a   Davies, F E ^a   Linet, M ^b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Epidemiology; Genetics; Myeloma

Indexed keywords

BENZENE; CHLORPHENOTANE; CYTOKINE; IMMUNOGLOBULIN HEAVY CHAIN; INTERLEUKIN 6; LYMPHOTOXIN; PARAPROTEIN; SOLVENT; TUMOR NECROSIS FACTOR ALPHA;

AGRICULTURE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RISK; CARCINOGENESIS; CHROMOSOME ANALYSIS; CLINICAL FEATURE; GENETIC POLYMORPHISM; HUMAN; IMMUNOPATHOLOGY; IONIZING RADIATION; LYMPHOCYTE PROLIFERATION; MOLECULAR DYNAMICS; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; MUTATIONAL ANALYSIS; MYELOID LEUKEMIA; MYELOMA; NONHUMAN; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; PRIORITY JOURNAL; RADIATION EXPOSURE; REVIEW;

ANIMALS; HUMANS; MULTIPLE MYELOMA;

EID: 0036630035     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(02)00194-4     Document Type: Review

References (221)

1. Adami J., Nyren O., Bergstrom R., Ekbom A., Engholm G., Englund A., Glimelius B. Smoking and the risk of leukemia, lymphoma, and multiple myeloma (Sweden). Cancer Causes Control. 9:1998;49-56.
2. Allan T.M. ABO groups and myelomatosis. Br Med J. 4:1970;178.
3. Andersson M., Carstensen B., Visfeldt J. Leukemia and other related hematological disorders among Danish patients exposed to Thorotrast. Radiat Res. 134:1993;224-233.
4. Andersson M., Storm H.H. Cancer incidence among Danish Thorotrast-exposed patients. J Natl Cancer Inst. 84:1992;1318-1325.
5. Andjelkovich D., Taulbee J., Blum S. Mortality of female workers in rubber manufacturing plant. J Occup M. 20:1978;409-413.
6. Axelsson U., Bachmann R., Hallen J. Frequency of pathological proteins (M-components) om 6,995 sera from an adult population. Acta Med Scand. 179:1966;235-247.
7. Beral V., Newton R. Overview of the epidemiology of immunodeficiency-associated cancers. J Natl Cancer Inst Monogr. 1998;1-6.
8. Bergsagel D.E., Wong O., Bergsagel P.L., Alexanian R., Anderson K., Kyle R.A., Raabe G.K. Benzene and multiple myeloma: appraisal of the scientific evidence. Blood. 94:1999;1174-1182.
9. Berkheiser S.W. Review of leukemia, lymphoma, and myeloma before and after the TMI accident. Pa M. 89:1986;50-52.
10. Bertazzi A., Pesatori A.C., Consonni D., Tironi A., Landi M.T., Zocchetti C. Cancer incidence in a population accidentally exposed to 2,3,7,8-tetrachlorodibenzo-para-dioxin. Epidemiology. 4:1993;398-406.
11. Bertazzi P.A., Pesatori A.C., Bernucci I., Landi M.T., Consonni D. Dioxin exposure and human leukemias and lymphomas. Lessons from the Seveso accident and studies on industrial workers. Leukemia. 13:(Suppl 1):1999;S72-74.
12. Bertazzi P.A., Zocchetti C., Guercilena S., Consonni D., Tironi A., Landi M.T., Pesatori A.C. Dioxin exposure and cancer risk: a 15-year mortality study after the "Seveso accident" Epidemiology. 8:1997;646-652.
13. Bethwaite P.B., Pearce N., Fraser J. Cancer risks in painters: study based on the New Zealand Cancer Registry. Br J Ind M. 47:1990;742-746.
14. Bezabeh S., Engel A., Morris C.B., Lamm S.H. Does benzene cause multiple myeloma? An analysis of the published case-control literature. Environ Health Perspect. 104:(Suppl 6):1996;1393-1398.
15. Bithell J.F., Dutton S.J., Draper G.J., Neary N.M. Distribution of childhood leukaemias and non-Hodgkin's lymphomas near nuclear installations in England and Wales. BMJ. 309:1994;501-505.
16. Blade J., Lopez-Guillermo A., Rozman C., Cervantes F., Salgado C., Aguilar J.L., Vives-Corrons J.L., Montserrat E. Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance. Br J Haematol. 81:1992;391-394.
17. Blair A., Hartge P., Stewart P.A., McAdams M., Lubin J. Mortality and cancer incidence of aircraft maintenance workers exposed to trichloroethylene and other organic solvents and chemicals: extended follow up. Occup Environ M. 55:1998;161-171.
18. Blair A., Zahm S.H. Agricultural exposures and cancer. Environ Health Perspect. 103:(Suppl 8):1995;205-208.
19. Blair A., Zahm S.H., Pearce N.E., Heineman E.F., Fraumeni J.F. Jr. Clues to cancer etiology from studies of farmers. Scand J Work Environ Health. 18:1992;209-215.
20. Blattner W.A., Jacobson R.J., Shulman G. Multiple myeloma in South African blacks. Lancet. 1:1979;928-929.
21. Boffetta P., Stellman S.D., Garfinkel L. A case-control study of multiple myeloma nested in the American Cancer Society prospective study. Int J Cancer. 43:1989;554-559.
22. Boice J.D. Jr, Day N.E., Andersen A., Brinton L.A., Brown R., Choi N.W., Clarke E.A., Coleman M.P., Curtis R.E., Flannery J.T. Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries. J Natl Cancer Inst. 74:1985;955-975.
23. Boice Jr J.D., Morin M.M., Glass A.G., Friedman G.D., Stovall M., Hoover R.N., Fraumeni Jr J.F. Diagnostic x-ray procedures and risk of leukemia, lymphoma, and multiple myeloma. JAMA. 265:1991;1290-1294.
24. Bourguet C.C., Grufferman S., Delzell E., DeLong E.R., Cohen H.J. Multiple myeloma and family history of cancer. A case-control study. Cancer. 56:1985;2133-2139.
25. Bowden M., Crawford J., Cohen H.J., Noyama O. A comparative study of monoclonal gammopathies and immunoglobulin levels in Japanese and United States elderly. J Am Geriatr Soc. 41:1993;11-14.
26. Brown L.M., Burmeister L.F., Everett G.D., Blair A. Pesticide exposures and multiple myeloma in Iowa men. Cancer Causes Control. 4:1993;153-156.
27. Brown L.M., Everett G.D., Burmeister L.F., Blair A. Hair dye use and multiple myeloma in white men. Am J Public Health. 82:1992;1673-1674.
28. Brown L.M., Everett G.D., Gibson R., Burmeister L.F., Schuman L.M., Blair A. Smoking and risk of non-Hodgkin's lymphoma and multiple myeloma. Cancer Causes Control. 3:1992;49-55.
29. Brown L.M., Gibson R., Burmeister L.F., Schuman L.M., Everett G.D., Blair A. Alcohol consumption and risk of leukemia, non-Hodgkin's lymphoma, and multiple myeloma. Leuk Res. 16:1992;979-984.
30. Brown L.M., Linet M.S., Greenberg R.S., Silverman D.T., Hayes R.B., Swanson G.M., Schwartz A.G., Schoenberg J.B., Pottern L.M., Fraumeni Jr J.F. Multiple myeloma and family history of cancer among blacks and whites in the U.S. Cancer. 85:1999;2385-2390.
31. Brugiatelli M., Comis M., Iacopino P., Morabito F., Nobile F., Trapani L.V., Neri A. Multiple myeloma in husband and wife. Acta Haematol. 64:1980;227-229.
32. Caldwell G.G., Kelley D., Zack M., Falk H., Heath Jr C.W. Mortality and cancer frequency among military nuclear test (Smoky) participants, 1957 through 1979. JAMA. 250:1983;620-624.
33. Cartwright R.A., Alexander F.E., McKinney P.A., Ricketts T.J. Leukaemia and lymphoma: an atlas of distribution within areas of England and Wales 1984-1988. 1990;Leukaemia Research Fund, London.
34. Cartwright R.A., McNally R.J.Q., Rowland D.J., Thomas J. The descriptive epidemiology of leukaemia and related conditions in parts of the United Kingdom 1984-1993. 1997;Leukaemia Research Fund, London.
35. Cerhan J.R., Cantor K.P., Williamson K., Lynch C.F., Torner J.C., Burmeister L.F. Cancer mortality among Iowa farmers: recent results, time trends, and lifestyle factors (United States). Cancer Causes Control. 9:1998;311-319.
36. Chatenoud L., Tavani A., La Vecchia C., Jacobs Jr D.R., Negri E., Levi F., Franceschi S. Whole grain food intake and cancer risk. Int J Cancer. 77:1998;24-28.
37. Chiu B.C., Cerhan J.R., Folsom A.R., Sellers T.A., Kushi L.H., Wallace R.B., Zheng W., Potter J.D. Diet and risk of non-Hodgkin lymphoma in older women. JAMA. 275:1996;1315-1321.
38. Cocco P., Blair A., Congia P., Saba G., Ecca A.R., Palmas C. Long-term health effects of the occupational exposure to DDT. A preliminary report. Ann NY Acad Sci. 837:1997;246-256.
39. Cohen H.J., Crawford J., Rao M.K., Pieper C.F., Currie M.S. Racial differences in the prevalence of monoclonal gammopathy in a community-based sample of the elderly. Am J M. 104:1998;439-444.
40. Coleman M.P., Esteve J., Damiecki P., Arslan A., Renard H. Trends in cancer incidence and mortality. IARC Sci Publ. 1993;1-806.
41. Comotti B., Bassan R., Buzzetti M., Finazzi G., Barbui T. Multiple myeloma in a pair of twins. Br J Haematol. 65:1987;123-124.
42. Cook-Mozaffari P., Darby S., Doll R. Cancer near potential sites of nuclear installations. Lancet. 2:1989;1145-1147.
43. Correa A., Jackson L., Mohan A., Perry H., Helzlsouer K. Use of hair dyes, hematopoietic neoplasms, and lymphomas: a literature review. II. Lymphomas and multiple myeloma. Cancer Invest. 18:2000;467-479.
44. Crump K.S. Risk of benzene-induced leukemia predicted from the Pliofilm cohort. Environ Health Perspect. 104:(Suppl 6):1996;1437-1441.
45. Cuzick J. Radiation-induced myelomatosis. N Engl J M. 304:1981;204-210.
46. Cuzick J., De Stavola B. Multiple myeloma - A case-control study. Br J Cancer. 57:1988;516-520.
47. Darby S.C., Doll R., Gill S.K., Smith P.G. Long term mortality after a single treatment course with X-rays in patients treated for ankylosing spondylitis. Br J Cancer. 55:1987;179-190.
48. Darby S.C., Kendall G.M., Fell T.P., O'Hagan J.A., Muirhead C.R., Ennis J.R., Ball A.M., Dennis J.A., Doll R. A summary of mortality and incidence of cancer in men from the United Kingdom who participated in the United Kingdom's atmospheric nuclear weapon tests and experimental programmes. Br Med J (Clin Res Ed). 296:1988;332-338.
49. Darby S.C., Reeves G., Key T., Doll R., Stovall M. Mortality in a cohort of women given X-ray therapy for metropathia haemorrhagica. Int J Cancer. 56:1994;793-801.
50. Davies F.E., Rollinson S.J., Rawstron A.C., Roman E., Richards S., Drayson M., Child J.A., Morgan G.J. High-producer haplotypes of tumor necrosis factor alpha and lymphotoxin alpha are associated with an increased risk of myeloma and have an improved progression-free survival after treatment. J Clin Oncol. 18:2000;2843-2851.
51. Davis F.G., Boice Jr J.D., Hrubec Z., Monson R.R. Cancer mortality in a radiation-exposed cohort of Massachusetts tuberculosis patients. Cancer Res. 49:1989;6130-6136.
52. Delzell E., Monson R.R. Mortality among rubber workers: X. Reclaim workers. Am J Ind M. 7:1985;307-313.
53. Dement J.M., Hensley L., Kieding S., Lipscomb H. Proportionate mortality among union members employed at three Texas refineries. Am J Ind M. 33:1998;327-340.
54. Demers P.A., Vaughan T.L., Koepsell T.D., Lyon J.L., Swanson G.M., Greenberg R.S., Weiss N.S. A case-control study of multiple myeloma and occupation. Am J Ind M. 23:1993;629-639.
55. Divine B.J., Hartman C.M. Mortality update of butadiene production workers. Toxicology. 113:1996;169-181.
56. Divine B.J., Hartman C.M., Wendt J.K. Update of the Texaco mortality study 1947-93: Part II. Analyses of specific causes of death for white men employed in refining, research, and petrochemicals. Occup Environ M. 56:1999;174-180.
57. Doody M.M., Linet M.S., Glass A.G., Friedman G.D., Pottern L.M., Boice J.D. Jr, Fraumeni J.F. Jr. Leukemia, lymphoma, and multiple myeloma following selected medical conditions. Cancer Causes Control. 3:1992;449-456.
58. Doody M.M., Mandel J.S., Lubin J.H., Boice J.D. Jr. Mortality among United States radiologic technologists, 1926-90. Cancer Causes Control. 9:1998;67-75.
59. Dosemeci M., Yin S.N., Linet M., Wacholder S., Rothman N., Li G.L., Chow W.H., Wang Y.Z., Jiang Z.L., Dai T.R., Zhang W.U., Chao X.J., Ye P.Z., Kou Q.R., Fan Y.H., Zhang X.C., Lin X.F., Meng J.F., Zho J.S., Blot W.J., Hayes R.B. Indirect validation of benzene exposure assessment by association with benzene poisoning. Environ Health Perspect. 104:(Suppl 6):1996;1343-1347.
60. Dring A.M., Davies F.E., Rollinson S.J., Roddam P.L., Rawstron A.C., Child J.A., Jack A.S., Morgan G.J. Interleukin 6, tumour necrosis factor alpha and lymphotoxin polymorphisms in monoclonal gammopathy of uncertain significance and multiple myeloma. Br J Haematol. 112:2001;249-250.
61. Ende M. Multiple myeloma: a cluster in Virginia? Va M. 106:1979;115-116.
62. Eriksson M. Rheumatoid arthritis as a risk factor for multiple myeloma: a case-control study. Eur J Cancer. 29A:1993;259-263.
63. Eriksson M., Hallberg B. Familial occurrence of hematologic malignancies and other diseases in multiple myeloma: a case-control study. Cancer Causes Control. 3:1992;63-67.
64. Eriksson M., Hardell L., Malker H., Weiner J. Malignant lymphoproliferative diseases in occupations with potential exposure to phenoxyacetic acids or dioxins: a register-based study. Am J Ind M. 22:1992;305-312.
65. Eriksson M., Karlsson M. Occupational and other environmental factors and multiple myeloma: a population based case-control study. Br J Ind M. 49:1992;95-103.
66. Fester J., Marrink J., Sijpesteijn J. A study on the association between myelomatosis and immunoglobulin all types, HLA, and blood groups. Immunogen. 3:1976;201.
67. Figgs L.W., Dosemeci M., Blair A. Risk of multiple myeloma by occupation and industry among men and women: a 24-state death certificate study. J Occup M. 36:1994;1210-1221.
68. Finch S. Leukaemia and lymphoma in atomic bomb survivors. Boice J.D. Jr, Fraumeni J.F. Jr, . Radiation carcinogenesis: epidemiology and biological significance. 1984;37-44 Raven Press, New York.
69. Fingerhut M.A., Halperin W.E., Marlow D.A., Piacitelli L.A., Honchar P.A., Sweeney M.H., Greife A.L., Dill P.A., Steenland K., Suruda A.J. Cancer mortality in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. N Engl J M. 324:1991;212-218.
70. Fishman D., Faulds G., Jeffery R., Mohamed-Ali V., Yudkin J.S., Humphries S., Woo P. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest. 102:1998;1369-1376.
71. Flodin U., Fredriksson M., Persson B. Multiple myeloma and engine exhausts, fresh wood, and creosote: a case-referent study. Am J Ind M. 12:1987;519-529.
72. Fox A.J., Collier P.F. A survey of occupational cancer in the rubber and cablemaking industries: analysis of deaths occurring in 1972-74. Br J Ind M. 33:1976;249-264.
73. Friedman G.D. Multiple myeloma: relation to propoxyphene and other drugs, radiation and occupation. Int J Epidemiol. 15:1986;424-426.
74. Friedman G.D. Cigarette smoking, leukemia, and multiple myeloma. Ann Epidemiol. 3:1993;425-428.
75. Fritschi L., Siemiatycki J. Lymphoma, myeloma and occupation: results of a case-control study. Int J Cancer. 67:1996;498-503.
76. Fu H., Demers P.A., Costantini A.S., Winter P., Colin D., Kogevinas M., Boffetta P. Cancer mortality among shoe manufacturing workers: an analysis of two cohorts. Occup Environ M. 53:1996;394-398.
77. Gallagher R.P., Spinelli J.J., Elwood J.M., Skippen D.H. Allergies and agricultural exposure as risk factors for multiple myeloma. Br J Cancer. 48:1983;853-857.
78. Gardner M.J., Snee M.P., Hall A.J., Powell C.A., Downes S., Terrell J.D. Results of case-control study of leukaemia and lymphoma among young people near Sellafield nuclear plant in West Cumbria. BMJ. 300:1990;423-429.
79. Gibson R., Graham S., Lilienfeld A., Schuman L., Dowd J.E., Levin M.L. Irradiation in the epidemiology of leukemia among adults. J Natl Cancer Inst. 48:1972;301-311.
80. Gilbert E.S., Marks S. An analysis of the mortality of workers in a nuclear facility. Radiat Res. 79:1979;122-148.
81. Gilbert E.S., Omohundro E., Buchanan J.A., Holter N.A. Mortality of workers at the Hanford site: 1945-1986. Health Phys. 64:1993;577-590.
82. Gilbert E.S., Petersen G.R., Buchanan J.A. Mortality of workers at the Hanford site: 1945-1981. Health Phys. 56:1989;11-25.
83. Goedert J.J., Cote T.R., Virgo P., Scoppa S.M., Kingma D.W., Gail M.H., Jaffe E.S., Biggar R.J. Spectrum of AIDS-associated malignant disorders. Lancet. 351:1998;1833-1839.
84. Goldgar D.E., Easton D.F., Cannon-Albright L.A., Skolnick M.H. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst. 86:1994;1600-1608.
85. Goldstein B.D., Shalat S.L. The casual relation between benzene exposure and multiple myeloma. Blood. 95:2000;1512-1514.
86. Gramenzi A., Buttino I., D'Avanzo B., Negri E., Franceschi S., La Vecchia C. Medical history and the risk of multiple myeloma. Br J Cancer. 63:1991;769-772.
87. Gregersen H., Mellemkjaer L., Salling I.J., Sorensen H.T., Olsen J.H., Pedersen J.O., Dahlerup J.F. Cancer risk in patients with monoclonal gammopathy of undetermined significance. Am J Hematol. 63:2000;1-6.
88. Griem M.L., Kleinerman R.A., Boice Jr J.D., Stovall M., Shefner D., Lubin J.H. Cancer following radiotherapy for peptic ulcer. J Natl Cancer Inst. 86:1994;842-849.
89. Grosbois B., Jego P., Attal M., Payen C., Rapp M.J., Fuzibet J.G., Maigre M., Bataille R. Familial multiple myeloma: report of fifteen families. Br J Haematol. 105:1999;768-770.
90. Grufferman S., Cohen H.J., Delzell E.S., Morrison M.C., Schold Jr S.C., Moore J.O. Familial aggregation of multiple myeloma and central nervous system diseases. J Am Geriatr Soc. 37:1989;303-309.
91. Grulich A.E., Wan X., Law M.G., Coates M., Kaldor J.M. Risk of cancer in people with AIDS. AIDS. 13:1999;839-843.
92. Gustavsson P., Hogstedt C., Holmberg B. Mortality and incidence of cancer among Swedish rubber workers, 1952-1981. Scand J Work Environ Health. 12:1986;538-544.
93. Hayes R.B., Yin S.N., Dosemeci M., Li G.L., Wacholder S., Travis L.B., Li C.Y., Rothman N., Hoover R.N., Linet M.S. Benzene and the dose-related incidence of hematologic neoplasms in China. Chinese Academy of Preventive Medicine-National Cancer Institute Benzene Study Group. J Natl Cancer Inst. 89:1997;1065-1071.
94. Heineman E.F., Zahm S.H., McLaughlin J.K., Vaught J.B., Hrubec Z. A prospective study of tobacco use and multiple myeloma: evidence against an association. Cancer Causes Control. 3:1992;31-36.
95. Herrinton L.J. The epidemiology of monoclonal gammopathy of unknown significance: a review. Curr Top Microbiol Immunol. 210:1996;389-395.
96. Herrinton L.J., Demers P.A., Koepsell T.D., Weiss N.S., Daling J.R., Taylor J.W., Lyon J.L., Swanson G.M., Greenberg R.S. Epidemiology of the M-component immunoglobulin types of multiple myeloma. Cancer Causes Control. 4:1993;83-92.
97. Herrinton L.J., Weiss N.S., Koepsell T.D., Daling J.R., Taylor J.W., Lyon J.L., Swanson G.M., Greenberg R.S. Exposure to hair-coloring products and the risk of multiple myeloma. Am J Public Health. 84:1994;1142-1144.
98. Herrinton L.J., Weiss N.S., Olshan A.F. Epidemiology of multiple myeloma. Malpas J.P., Bergsagel D.E., Kyle R.A., Myeloma-biology and management. 1995;1127-1141 Oxford University Press, Oxford, England.
99. Herrinton L.J., Weiss N.S., Olshan A.F. Multiple myeloma. Schottenfeld D., Fraumeni J.F. Jr, . Cancer epidemiology and prevention. 1996;946-970 Oxford University Press, New York.
100. Holm L.E., Hall P., Wiklund K., Lundell G., Berg G., Bjelkengren G., Cederquist E., Ericsson U.B., Hallquist A., Larsson L.G. Cancer risk after iodine-131 therapy for hyperthyroidism. J Natl Cancer Inst. 83:1991;1072-1077.
101. Huebner W.W., Schnatter A.R., Nicolich M.J., Jorgensen G. Mortality experience of a young petrochemical industry cohort. 1979-1992 follow-up study of US-based employees. J Occup Environ M. 39:1997;970-982.
102. Ichimaru M., Ishimaru T., Belsky J.L. Incidence of leukemia in atomic bomb survivors belonging to a fixed cohort in Hiroshima and Nagasaki, 1950-71. Radiation dose, years after exposure, age at exposure, and type of leukemia. J Radiat Res (Tokyo). 19:1978;262-282.
103. Ichimaru M., Ishimaru T., Mikami M., Matsunaga M. Multiple myeloma among atomic bomb survivors in Hiroshima and Nagasaki, 1950-76: relationship to radiation dose absorbed by marrow. J Natl Cancer Inst. 69:1982;323-328.
104. Inskip P.D., Kleinerman R.A., Stovall M., Cookfair D.L., Hadjimichael O., Moloney W.C., Monson R.R., Thompson W.D., Wactawski-Wende J., Wagoner J.K. Leukemia, lymphoma, and multiple myeloma after pelvic radiotherapy for benign disease. Radiat Res. 135:1993;108-124.
105. Inskip P.D., Monson R.R., Wagoner J.K., Stovall M., Davis F.G., Kleinerman R.A., Boice Jr J.D. Leukemia following radiotherapy for uterine bleeding. Radiat Res. 122:1990;107-119.
106. Ireland B., Collins J.J., Buckley C.F., Riordan S.G. Cancer mortality among workers with benzene exposure. Epidemiology. 8:1997;318-320.
107. Isobe T., Osserman E.F. Pathologic conditions associated with plasma cell dyscrasias: a study of 806 cases. Ann NY Acad Sci. 190:1971;507-518.
108. Isomaki H.A., Hakulinen T., Joutsenlahti U. Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis. J Chronic Dis. 31:1978;691-696.
109. Jablon S., Miller R.W. Army technologists: 29-year follow up for cause of death. Radiology. 126:1978;677-679.
110. Jensen O.M. Cancer morbidity and causes of death among Danish brewery workers. Int J Cancer. 23:1979;454-463.
111. Johnston J.M., Grufferman S., Bourguet C.C., Delzell E., DeLong E.R., Cohen H.J. Socioeconomic status and risk of multiple myeloma. J Epidemiol Community Health. 39:1985;175-178.
112. Judson I.R., Wiltshaw E., Newland A.C. Multiple myeloma in a pair of monozygotic twins: the first reported case. Br J Haematol. 60:1985;551-554.
113. Kanoh T. Multiple myeloma in spouses. Eur J Haematol. 41:1988;397.
114. Kanoh T., Ohno T., Usui T., Inamoto Y. Multiple myeloma in husband and wife. Nippon Ketsueki Gakkai Zasshi. 52:1989;763-766.
115. Katusic S., Beard C.M., Kurland L.T., Weis J.W., Bergstralh E. Occurrence of malignant neoplasms in the Rochester, Minnesota, rheumatoid arthritis cohort. Am J M. 78:1985;50-55.
116. Keshava-Prasad H.S., Prangnell D.R., Adelman M.I. Multiple myeloma in spouses. Clin Lab Haematol. 18:1996;61-62.
117. Khuder S.A., Mutgi A.B. Meta-analyses of multiple myeloma and farming. Am J Ind M. 32:1997;510-516.
118. Koepsell T.D., Daling J.R., Weiss N.S., Taylor J.W., Olshan A.F., Lyon J.L., Swanson G.M., Child M. Antigenic stimulation and the occurrence of multiple myeloma. Am J Epidemiol. 126:1987;1051-1062.
119. Kogevinas M., Becher H., Benn T., Bertazzi P.A., Boffetta P., Bueno-de-Mesquita H.B., Coggon D., Colin D., Flesch-Janys D., Fingerhut M., Green L., Kauppinen T., Littorin M., Lynge E., Mathews J.D., Neuberger M., Pearce N., Saracci R. Cancer mortality in workers exposed to phenoxy herbicides, chlorophenols, and dioxins. An expanded and updated international cohort study. Am J Epidemiol. 145:1997;1061-1075.
120. Kogevinas M., Ferro G., Saracci R., Andersen A., Biocca M., Coggon D., Gennaro V., Hutchings S., Kolstad H., Lundberg I. Cancer mortality in an international cohort of workers exposed to styrene. IARC Sci Publ. 1993;289-300.
121. Kogevinas M., Sala M., Boffetta P., Kazerouni N., Kromhout H., Hoar-Zahm S. Cancer risk in the rubber industry: a review of the recent epidemiological evidence. Occup Environ M. 55:1998;1-12.
122. Kosaka M., Okagawa K., Miyamoto Y., Goto T., Saito S. Geographic clustering of myeloma in Tokushima. Int J Hematol. 54:1991;405-409.
123. Kristensen P., Andersen A., Irgens L.M., Laake P., Bye A.S. Incidence and risk factors of cancer among men and women in Norwegian agriculture. Scand J Work Environ Health. 22:1996;14-26.
124. Kyle R.A. "Benign" monoclonal gammopathy-after 20 to 35 years of follow-up. Mayo Clin Proc. 68:1993;26-36.
125. Kyle R.A., Finkelstein S., Elveback L.R., Kurland L.T. Incidence of monoclonal proteins in a Minnesota community with a cluster of multiple myeloma. Blood. 40:1972;719-724.
126. Kyle R.A., Greipp P.R. Multiple myeloma. Houses and spouses. Cancer. 51:1983;735-739.
127. Kyle R.A., Heath Jr C.W., Carbone P. Multiple myeloma in spouses. Arch Intern M. 127:1971;944-946.
128. Kyle R.A., Herber L., Evatt B.L., Heath Jr C.W. Multiple myeloma. A community cluster. JAMA. 213:1970;1339-1341.
129. Kyle R.A., Rajkumar S.V. Monoclonal gammopathies of undetermined significance. Hematol Oncol Clin North Am. 13:1999;1181-1202.
130. Lewis D.R., Pottern L.M., Brown L.M., Silverman D.T., Hayes R.B., Schoenberg J.B., Greenberg R.S., Swanson G.M., Schwartz A.G., Liff J.M. Multiple myeloma among blacks and whites in the United States: the role of chronic antigenic stimulation. Cancer Causes Control. 5:1994;529-539.
131. Lewis E.B. Leukaemia, multiple myeloma and aplastic anemia in American radiologists. Science. 142:1963;1492-1494.
132. Linet M.S. Is chronic antigenic stimulation etiologically related to multiple myeloma? Obrams G.I., Potter M., Epidemiology and biology of multiple myeloma. 1991;99-105 Springer, Berlin.
133. Linet M.S., Harlow S.D., McLaughlin J.K. A case-control study of multiple myeloma in whites: chronic antigenic stimulation, occupation, and drug use. Cancer Res. 47:1987;2978-2981.
134. Linet M.S., McLaughlin J.K., Harlow S.D., Fraumeni J.F. Family history of autoimmune disorders and cancer in multiple myeloma. Int J Epidemiol. 17:1988;512-513.
135. Little M.P., Weiss H.A., Boice Jr J.D., Darby S.C., Day N.E., Muirhead C.R. Risks of leukemia in Japanese atomic bomb survivors, in women treated for cervical cancer, and in patients treated for ankylosing spondylitis. Radiat Res. 152:1999;280-292.
136. Lopez-Abente G., Aragones N., Pollan M., Ruiz M., Gandarillas A. Leukemia, lymphomas, and myeloma mortality in the vicinity of nuclear power plants and nuclear fuel facilities in Spain. Cancer Epidemiol Biomarkers Prev. 8:1999;925-934.
137. Ludwig H., Mayr W. Genetic aspects of susceptibility to multiple myeloma. Blood. 59:1982;1286-1291.
138. Lundberg I., Milatou-Smith R. Mortality and cancer incidence among Swedish paint industry workers with long-term exposure to organic solvents. Scand J Work Environ Health. 24:1998;270-275.
139. Mancuso T.F., Stewart A., Kneale G. Radiation exposures of Hanford workers dying from cancer and other causes. Health Phys. 33:1977;369-385.
140. Martling U., Mattsson A., Travis L.B., Holm L.E., Hall P. Mortality after long-term exposure to radioactive Thorotrast: a forty- year follow-up survey in Sweden. Radiat Res. 151:1999;293-299.
141. Massoudi B.L., Talbott E.O., Day R.D., Swerdlow S.H., Marsh G.M., Kuller L.H. A case-control study of hematopoietic and lymphoid neoplasms: the role of work in the chemical industry. Am J Ind M. 31:1997;21-27.
142. McLaughlin J.K., Malker H.S., Linet M.S., Ericsson J., Stone B.J., Weiner J., Blot W.J., Fraumeni Jr J.F. Multiple myeloma and occupation in Sweden. Arch Environ Health. 43:1988;7-10.
143. Metayer C., Johnson E.S., Rice J.C. Nested case-control study of tumors of the hemopoietic and lymphatic systems among workers in the meat industry. Am J Epidemiol. 147:1998;727-738.
144. Milham Jr S. Leukemia and multiple myeloma in farmers. Am J Epidemiol. 94:1971;507-510.
145. Miller R.W. Deaths from childhood leukemia and solid tumors among twins and other sibs in the United States, 1960-67. J Natl Cancer Inst. 46:1971;203-209.
146. Mills P.K., Newell G.R., Beeson W.L., Fraser G.E., Phillips R.L. History of cigarette smoking and risk of leukemia and myeloma: results from the Adventist health study. J Natl Cancer Inst. 82:1990;1832-1836.
147. Monson R.R., Nakano K.K. Mortality among rubber workers. II. Other employees. Am J Epidemiol. 103:1976;297-303.
148. Morgan R.W., Claxton K.W., Divine B.J., Kaplan S.D., Harris V.B. Mortality among ethylene oxide workers. J Occup M. 23:1981;767-770.
149. Muirhead C.R., Goodill A.A., Haylock R.G., Vokes J., Little M.P., Jackson D.A., O'Hagan J.A., Thomas J.M., Kendall G.M., Silk T.J., Bingham D., Berridge G.L. Occupational radiation exposure and mortality: second analysis of the National Registry for Radiation Workers. J Radiol Prot. 19:1999;3-26.
150. Nandakumar A., Armstrong B.K., de Klerk N.H. Multiple myeloma in Western Australia: a case-control study in relation to occupation, father's occupation, socioeconomic status and country of birth. Int J Cancer. 37:1986;223-226.
151. Neriishi K., Yoshimoto Y., Carter R.L., Matsuo T., Ichimaru M., Mikami M., Abe T., Fujimura K., Kuramoto A. Monoclonal gammopathy in atomic bomb survivors. Radiat Res. 133:1993;351-359.
152. Nilsson R.I., Nordlinder R., Horte L.G., Jarvholm B. Leukaemia, lymphoma, and multiple myeloma in seamen on tankers. Occup Environ M. 55:1998;517-521.
153. Nishiyama H., Anderson R.E., Ishimaru T., Ishida K., Ii Y., Okabe N. The incidence of malignant lymphoma and multiple myeloma in Hiroshima and Nagasaki atomic bomb survivors, 1945-1965. Cancer. 32:1973;1301-1309.
154. Parkin D.M., Muir C.S. Cancer incidence in five continents. Comparability and quality of data. IARC Sci Publ. 1992;45-173.
155. Pasqualetti P., Casale R. Risk of malignant transformation in patients with monoclonal gammopathy of undetermined significance. Biomed Pharmacother. 51:1997;74-78.
156. Pearce N., Prior I., Methven D., Culling C., Marshall S., Auld J., de Boer G., Bethwaite P. Follow up of New Zealand participants in British atmospheric nuclear weapons tests in the Pacific. BMJ. 300:1990;1161-1166.
157. Pearce N.E., Smith A.H., Howard J.K., Sheppard R.A., Giles H.J., Teague C.A. Case-control study of multiple myeloma and farming. Br J Cancer. 54:1986;493-500.
158. Pierce D.A., Shimizu Y., Preston D.L., Vaeth M., Mabuchi K. Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950-1990. Radiat Res. 146:1996;1-27.
159. Pietruszka M., Rabin B.S., Srodes C. Letter: multiple myeloma in husband and wife. Lancet. 1:1976;314.
160. Polednak A.P., Stehney A.F., Rowland R.E. Mortality among women first employed before 1930 in the U.S. radium dial-painting industry. A group ascertained from employment lists. Am J Epidemiol. 107:1978;179-195.
161. Potter M., Morrison S., Wiener F., Zhang X.K., Miller F.W. Induction of plasmacytomas with silicone gel in genetically susceptible strains of mice. J Natl Cancer Inst. 86:1994;1058-1065.
162. Pottern L.M., Gart J.J., Nam J.M., Dunston G., Wilson J., Greenberg R., Schoenberg J., Swanson G.M., Liff J., Schwartz A.G. HLA and multiple myeloma among black and white men: evidence of a genetic association. Cancer Epidemiol Biomarkers Prev. 1:1992;177-182.
163. Pottern L.M., Heineman E.F., Olsen J.H., Raffn E., Blair A. Multiple myeloma among Danish women: employment history and workplace exposures. Cancer Causes Control. 3:1992;427-432.
164. Preston D.L., Kusumi S., Tomonaga M., Izumi S., Ron E., Kuramoto A., Kamada N., Dohy H., Matsuo T., Matsui T. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987. Radiat Res. 137:1994;S68-S97.
165. Preston D.L., Pierce D.A. The effect of changes in dosimetry on cancer mortality risk estimates in the atomic bomb survivors. Radiat Res. 114:1988;437-466.
166. Pukkala E., Notkola V. Cancer incidence among Finnish farmers, 1979-93. Cancer Causes Control. 8:1997;25-33.
167. Raabe G.K., Collingwood K.W., Wong O. An updated mortality study of workers at a petroleum refinery in Beaumont, Texas. Am J Ind M. 33:1998;61-81.
168. Rettig M.B., Ma H.J., Vescio R.A., Pold M., Schiller G., Belson D., Savage A., Nishikubo C., Wu C., Fraser J., Said J.W., Berenson J.R. Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients. Science. 276:1997;1851-1854.
169. Riedel D.A., Pottern L.M. The epidemiology of multiple myeloma. Hematol Oncol Clin North Am. 6:1992;225-247.
170. Ries L.A., Eisner M.P., Kosary C.L., Hankey B.F., Miller B.A., Clegg L.X., Edwards B.K. SEER Cancer Statistics Review, 1973-1997. U.S. DHHS, PHS, NIH, Publ No. 00. 2000;2789.
171. Rinsky R.A., Smith A.B., Hornung R., Filloon T.G., Young R.J., Okun A.H., Landrigan P.J. Benzene and leukemia. An epidemiologic risk assessment. N Engl J M. 316:1987;1044-1050.
172. Ron E., Modan B., Boice Jr J.D. Mortality after radiotherapy for ringworm of the scalp. Am J Epidemiol. 127:1988;713-725.
173. Ron E., Preston D.L., Mabuchi K., Thompson D.E., Soda M. Cancer incidence in atomic bomb survivors. Part IV: comparison of cancer incidence and mortality. Radiat Res. 137:1994;S98-S112.
174. Saleun J.P., Vicariot M., Deroff P., Morin J.F. Monoclonal gammopathies in the adult population of Finistere, France. J Clin Pathol. 35:1982;63-68.
175. Saracci R., Kogevinas M., Bertazzi P.A., Bueno de Mesquita B.H., Coggon D., Green L.M., Kauppinen T., L'Abbe K.A., Littorin M., Lynge E. Cancer mortality in workers exposed to chlorophenoxy herbicides and chlorophenols. Lancet. 338:1991;1027-1032.
176. Sathiakumar N., Delzell E., Hovinga M., Macaluso M., Julian J.A., Larson R., Cole P., Muir D.C. Mortality from cancer and other causes of death among synthetic rubber workers. Occup Environ M. 55:1998;230-235.
177. Savitz D.A., Andrews K.W. Review of epidemiologic evidence on benzene and lymphatic and hematopoietic cancers. Am J Ind M. 31:1997;287-295.
178. Schechter G.P., Shoff N., Chan C. The frequency of monoclonal gammopathy of unknown significance in Black and Caucasian veterans in a hospital population. Obrams G.I., Potter M., Epidemiology and biology of multiple myeloma. 1991;83-85 Springer, New York.
179. Schnatter A.R., Armstrong T.W., Nicolich M.J., Thompson F.S., Katz A.M., Huebner W.W., Pearlman E.D. Lymphohaematopoietic malignancies and quantitative estimates of exposure to benzene in Canadian petroleum distribution workers. Occup Environ M. 53:1996;773-781.
180. Schnatter A.R., Armstrong T.W., Thompson L.S., Nicolich M.J., Katz A.M., Huebner W.W., Pearlman E.D. The relationship between low-level benzene exposure and leukemia in Canadian petroleum distribution workers. Environ Health Perspect. 104:(Suppl 6):1996;1375-1379.
181. Schnatter A.R., Theriault G., Katz A.M., Thompson F.S., Donaleski D., Murray N. A retrospective mortality study within operating segments of a petroleum company. Am J Ind M. 22:1992;209-229.
182. Schwartz G.G. Multiple myeloma: clusters, clues, and dioxins. Cancer Epidemiol Biomarkers Prev. 6:1997;49-56.
183. Seltser R., Sartwell P.E. The influence of occupational exposure to radiation on the mortality of American radiologists and other medical specialists. Am J Epidemiol. 81:1965;2-22.
184. Shimizu Y., Schull W.J., Kato H. Cancer risk among atomic bomb survivors. The RERF Life Span Study. Radiation Effects Research Foundation. JAMA. 264:1990;601-604.
185. Shore R.E., Albert R.E., Pasternack B.S. Follow-up study of patients treated by X-ray epilation for Tinea capitis;resurvey of post-treatment illness and mortality experience. Arch Environ Health. 31:1976;21-28.
186. Shpilberg O., Modan M., Modan B., Chetrit A., Fuchs Z., Ramot B. Familial aggregation of haematological neoplasms: a controlled study. Br J Haematol. 87:1994;75-80.
187. Shulman G., Jacobson R.J. Immunocytoma in black and white South Africans. Trop Geogr M. 32:1980;112-117.
188. Simmons Z., Albers J.W., Bromberg M.B., Feldman E.L. Long-term follow-up of patients with chronic inflammatory demyelinating polyradiculoneuropathy, without and with monoclonal gammopathy. Brain. 118:(Pt 2):1995;359-368.
189. Singh J., Dudley Jr A.W., Kulig K.A. Increased incidence of monoclonal gammopathy of undetermined significance in blacks and its age-related differences with whites on the basis of a study of 397 men and one woman in a hospital setting. J Lab Clin M. 116:1990;785-789.
190. Smith P.G., Doll R. Late effects of x irradiation in patients treated for metropathia haemorrhagica. Br J Radiol. 49:1976;224-232.
191. Smith P.G., Douglas A.J. Mortality of workers at the Sellafield plant of British Nuclear Fuels. Br Med J (Clin Res Ed). 293:1986;845-854.
192. Spinelli J.J., Gallagher R.P., Band P.R., Threlfall W.J. Multiple myeloma, leukemia, and cancer of the ovary in cosmetologists and hairdressers. Am J Ind M. 6:1984;97-102.
193. Stebbings J.H., Lucas H.F., Stehney A.F. Mortality from cancers of major sites in female radium dial workers. Am J Ind M. 5:1984;435-459.
194. Steenland K., Piacitelli L., Deddens J., Fingerhut M., Chang L.I. Cancer, heart disease, and diabetes in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Natl Cancer Inst. 91:1999;779-786.
195. Steenland K., Stayner L., Greife A., Halperin W., Hayes R., Hornung R., Nowlin S. Mortality among workers exposed to ethylene oxide. N Engl J M. 324:1991;1402-1407.
196. Steineck G., Wiklund K. Multiple myeloma in Swedish agricultural workers. Int J Epidemiol. 15:1986;321-325.
197. Svensson B.G., Mikoczy Z., Stromberg U., Hagmar L. Mortality and cancer incidence among Swedish fishermen with a high dietary intake of persistent organochlorine compounds. Scand J Work Environ Health. 21:1995;106-115.
198. Teta M.J., Walrath J., Meigs J.W., Flannery J.T. Cancer incidence among cosmetologists. J Natl Cancer Inst. 72:1984;1051-1057.
199. Tisdale J.F., Stewart A.K., Dickstein B., Little R.F., Dube I., Cappe D., Dunbar C.E., Brown K.E. Molecular and serological examination of the relationship of human herpesvirus 8 to multiple myeloma: orf 26 sequences in bone marrow stroma are not restricted to myeloma patients and other regions of the genome are not detected. Blood. 92:1998;2681-2687.
200. UNSCEAR (United Nations Scientific Committee on the Effects of Atomic Radiation) . Sources, effects and risks of ionizing radiation. 1988;29-293 United Nations, New York.
201. UNSCEAR (United Nations Scientific Committee on the Effects of Atomic Radiation) . Sources and effects of ionizing radiation. 1994;11-183 United Nations Publ No E.94.IX.11, New York.
202. UNSCEAR (United Nations Scientific Committee on the Effects of Atomic Radiation) . Sources and effects of ionizing radiation. 2000;297-431 United Nations Publ No E.00.IX.3, New York.
203. Van Kaick G., Dalheimer A., Hornik S., Kaul A., Liebermann D., Luhrs H., Spiethoff A., Wegener K., Wesch H. The german thorotrast study: recent results and assessment of risks. Radiat Res. 152:1999;S64-71.
204. Velez R., Beral V., Cuzick J. Increasing trends of multiple myeloma mortality in England and Wales; 1950-79: are the changes real? J Natl Cancer Inst. 69:1982;387-392.
205. Wang J.X., Boice Jr J.D., Li B.X., Zhang J.Y., Fraumeni Jr J.F. Cancer among medical diagnostic x-ray workers in China. J Natl Cancer Inst. 80:1988;344-350.
206. Wang J.X., Inskip P.D., Boice Jr J.D., Li B.X., Zhang J.Y., Fraumeni Jr J.F. Cancer incidence among medical diagnostic X-ray workers in China, 1950 to 1985. Int J Cancer. 45:1990;889-895.
207. Weiss H.A., Darby S.C., Doll R. Cancer mortality following X-ray treatment for ankylosing spondylitis. Int J Cancer. 59:1994;327-338.
208. Wiklund K., Dich J. Cancer risks among male farmers in Sweden. Eur J Cancer Prev. 4:1995;81-90.
209. Wiklund K., Holm L.E. Trends in cancer risks among Swedish agricultural workers. J Natl Cancer Inst. 77:1986;657-664.
210. Wilcosky T.C., Checkoway H., Marshall E.G., Tyroler H.A. Cancer mortality and solvent exposures in the rubber industry. Am Ind Hyg Assoc J. 45:1984;809-811.
211. Williams A.R., Weiss N.S., Koepsell T.D., Lyon J.L., Swanson G.M. Infectious and noninfectious exposures in the etiology of light chain myeloma: a case-control study. Cancer Res. 49:1989;4038-4041.
212. Wong O. Risk of acute myeloid leukaemia and multiple myeloma in workers exposed to benzene. Occup Environ M. 52:1995;380-384.
213. Wong O., Raabe G.K. Multiple myeloma and benzene exposure in a multinational cohort of more than 250,000 petroleum workers. Regul Toxicol Pharmacol. 26:1997;188-199.
214. Wong O., Trent L.S., Whorton M.D. An updated cohort mortality study of workers exposed to styrene in the reinforced plastics and composites industry. Occup Environ M. 51:1994;386-396.
215. Wongsrichanalai C., Delzell E., Cole P. Mortality from leukemia and other diseases among workers at a petroleum refinery. J Occup M. 31:1989;106-111.
216. Yin S.N., Li G.L., Tain F.D., Fu Z.I., Jin C., Chen Y.J., Luo S.J., Ye P.Z., Zhang J.Z., Wang G.C. Leukaemia in benzene workers: a retrospective cohort study. Br J Ind M. 44:1987;124-128.
217. Yin S.N., Li G.L., Tain F.D., Fu Z.I., Jin C., Chen Y.J., Luo S.J., Ye P.Z., Zhang J.Z., Wang G.C. A retrospective cohort study of leukemia and other cancers in benzene workers. Environ Health Perspect. 82:1989;207-213.
218. Yin S.N., Linet M.S., Hayes R.B., Li G.L., Dosemeci M., Wang Y.Z., Chow W.H., Jiang Z.L., Wacholder S., Zhang W.U. Cohort study among workers exposed to benzene in China: I. General methods and resources. Am J Ind M. 26:1994;383-400.
219. Zahm S.H., Weisenburger D.D., Babbitt P.A., Saal R.C., Vaught J.B., Blair A. Use of hair coloring products and the risk of lymphoma, multiple myeloma, and chronic lymphocytic leukemia. Am J Public Health. 82:1992;990-997.
220. Zheng C., Huang D.R., Bergenbrant S., Sundblad A., Osterborg A., Bjorkholm M., Holm G., Yi Q. Interleukin 6, tumour necrosis factor alpha, interleukin 1beta and interleukin 1 receptor antagonist promoter or coding gene polymorphisms in multiple myeloma. Br J Haematol. 109:2000;39-45.
221. Zheng T.Z., Mayne S.T., Flannery J. The time trends of multiple myeloma in Connecticut, 1935-1987. Int J Cancer. 50:1992;163-164.